OHSU News

This email notification is intended as a heads up to OHSU communicators. It is not shared with external subscribers.

Driven by OHSU research, FDA approves new drug to prevent hearing loss in children with cancer

Driven by OHSU research, FDA approves new drug to prevent hearing loss in children with cancer

Treatment with sodium thiosulfate will improve health outcomes and quality of life for pediatric cancer patients.